DE69807420D1 - Pharmazeutische aerosolzusammensetzung - Google Patents

Pharmazeutische aerosolzusammensetzung

Info

Publication number
DE69807420D1
DE69807420D1 DE69807420T DE69807420T DE69807420D1 DE 69807420 D1 DE69807420 D1 DE 69807420D1 DE 69807420 T DE69807420 T DE 69807420T DE 69807420 T DE69807420 T DE 69807420T DE 69807420 D1 DE69807420 D1 DE 69807420D1
Authority
DE
Germany
Prior art keywords
aerosol composition
pharmaceutical aerosol
pharmaceutical
composition
aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69807420T
Other languages
English (en)
Other versions
DE69807420T2 (de
DE69807420T3 (de
Inventor
David Lewis
Davis Ganderton
Brian Meakin
Paolo Ventura
Gaetano Brambilla
Raffaella Garzia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69807420(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Publication of DE69807420D1 publication Critical patent/DE69807420D1/de
Publication of DE69807420T2 publication Critical patent/DE69807420T2/de
Application granted granted Critical
Publication of DE69807420T3 publication Critical patent/DE69807420T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69807420T 1997-06-13 1998-06-10 Pharmazeutische aerosolzusammensetzung Expired - Lifetime DE69807420T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9712434 1997-06-13
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions
PCT/EP1998/003533 WO1998056349A1 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition

Publications (3)

Publication Number Publication Date
DE69807420D1 true DE69807420D1 (de) 2002-10-02
DE69807420T2 DE69807420T2 (de) 2003-05-08
DE69807420T3 DE69807420T3 (de) 2006-11-16

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69807420T Expired - Lifetime DE69807420T3 (de) 1997-06-13 1998-06-10 Pharmazeutische aerosolzusammensetzung

Country Status (45)

Country Link
EP (2) EP1219293A3 (de)
JP (1) JP4380802B2 (de)
KR (1) KR100546239B1 (de)
CN (1) CN1138532C (de)
AR (1) AR012977A1 (de)
AT (1) ATE222751T1 (de)
AU (1) AU729966B2 (de)
BG (1) BG63906B1 (de)
BR (1) BR9805993B1 (de)
CA (1) CA2263445C (de)
CO (1) CO4940408A1 (de)
CZ (1) CZ295521B6 (de)
DE (1) DE69807420T3 (de)
DK (1) DK0920302T4 (de)
DZ (1) DZ2516A1 (de)
EA (1) EA001259B1 (de)
EE (1) EE03664B1 (de)
ES (1) ES2182351T5 (de)
GB (1) GB2326334A (de)
GE (1) GEP20012462B (de)
HK (1) HK1022271A1 (de)
HR (1) HRP980317B1 (de)
HU (1) HU228487B1 (de)
ID (1) ID21491A (de)
IL (1) IL128484A (de)
IN (1) IN189317B (de)
IS (1) IS2435B (de)
IT (1) IT1293803B1 (de)
MA (1) MA26507A1 (de)
ME (2) ME00333B (de)
MY (1) MY119074A (de)
NO (1) NO327775B1 (de)
NZ (1) NZ334149A (de)
PL (1) PL193721B1 (de)
PT (1) PT920302E (de)
RS (1) RS51274B (de)
SA (1) SA98190821B1 (de)
SI (1) SI0920302T2 (de)
SK (1) SK284430B6 (de)
TN (1) TNSN98087A1 (de)
TR (1) TR199900288T1 (de)
TW (1) TW555570B (de)
UA (1) UA70289C2 (de)
WO (1) WO1998056349A1 (de)
ZA (1) ZA985136B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
DE60031504T2 (de) 1999-09-11 2007-04-05 Glaxo Group Ltd., Greenford Fluticasonpropionat arzneizubereitung
ES2234694T3 (es) * 1999-11-23 2005-07-01 Glaxo Group Limited Formulaciones farmaceuticas de salmeterol.
ES2238334T3 (es) * 1999-12-24 2005-09-01 Glaxo Group Limited Formulacion farmaceutica en aerosol de salmeterol y propionato de fluticasona.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
SK286694B6 (sk) * 2000-05-22 2009-03-05 Chiesi Farmaceutici S.P.A. Aerosólový farmaceutický prostriedok
WO2002072067A2 (en) * 2001-03-12 2002-09-19 Glaxo Group Limited Pharmaceutical aerosol formulation
ES2222294T3 (es) 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Formulacion optimizada de tobramicina para administracion en forma de aerosol.
EP1340503A1 (de) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Lösung Aerosol Formulierung von Estern von 3,17-dihydroxy Oestratrien-Derivaten zur Lungenverabreichung
EP1340492A1 (de) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosolformulierungen zur pulmonalen Verabreichung von Arzneimitteln mit systemischer Wirkung
PT3536344T (pt) 2002-03-01 2020-03-26 Chiesi Farm Spa Formulação superfina de formoterol
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
EP1369113B1 (de) * 2002-06-06 2006-11-22 CHIESI FARMACEUTICI S.p.A. Lösung von Wirkstoffen in HFA-Treibgasen mittels Emulsionen
JP2006516545A (ja) * 2003-02-04 2006-07-06 クリサリス テクノロジーズ インコーポレイテッド パーフルオロカーボン及びハイドロフルオロカーボン製剤及びその製法及び使用法
ME00420B (me) * 2003-03-20 2011-12-20 Boehringer Ingelheim Pharmaceuticals Inc Formulacija, za inhalator u kojem se odmjerava doza, u kojoj se kao propelenti koriste hidro-fluoro-alkani
EP1915985A1 (de) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulierung für einen Dosierinhalator mit Hydrofluoralkanen als Treibstoffen
EP1595531A1 (de) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stabile Arzneimittellösung für Druckdosierinhalatoren
DK1809243T4 (da) 2004-07-02 2022-09-05 Boehringer Ingelheim Int Aerosolsuspensionsformuleringer med tg 227 ea som drivmiddel
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) * 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
CN101909652A (zh) * 2007-11-07 2010-12-08 阿斯利康(瑞典)有限公司 含有抗坏血酸衍生物的干粉制剂
WO2012032010A1 (en) * 2010-09-06 2012-03-15 Chiesi Farmaceutici S.P.A. Metered-dose inhaler and method of using the same
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
WO2013127738A1 (de) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Neue treibgashaltige tiotropium-formulierung
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
EP3174522A1 (de) 2014-07-29 2017-06-07 3M Innovative Properties Company Verfahren zur herstellung einer pharmazeutischen zusammensetzung
EP3436115B1 (de) 2016-03-31 2021-07-28 Chiesi Farmaceutici S.p.A. Aerosolinhalationsvorrichtung
GEP20217240B (en) * 2016-09-19 2021-03-25 Mexichem Fluor Sa De Cv Pharmaceutical composition

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE60226T1 (de) † 1986-03-10 1991-02-15 Kurt Burghart Pharmazeutikum sowie verfahren zu seiner herstellung.
DE3775960D1 (de) † 1986-03-10 1992-02-27 Burghart Kurt Pharmazeutische zubereitung sowie verfahren zur herstellung derselben.
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
CA2094266C (en) † 1990-10-18 1999-06-01 Robert K. Schultz Aerosol formulations of beclomethasone-17,21-dipropionate
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
CA2111003A1 (en) † 1991-06-10 1992-12-23 Julianne Fassberg Non-chlorofluorocarbon aerosol formulations
PT656207E (pt) † 1991-06-10 2001-11-30 Schering Corp Formulacoes de aerossois sem clorofluorocarbonetos
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
NZ246046A (en) * 1991-12-12 1995-12-21 Glaxo Group Ltd Aerosol comprising a particulate medicament in a fluorocarbon or chlorofluorohydrocarbon and a polar cosolvent
ES2099415T3 (es) * 1991-12-18 1997-05-16 Minnesota Mining & Mfg Formulaciones de aerosol en suspension.
WO1994013262A1 (en) * 1992-12-09 1994-06-23 Boehringer Ingelheim Pharmaceuticals, Inc. Stabilized medicinal aerosol solution formulations
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
EP0759744B1 (de) † 1994-05-13 2001-10-17 Aradigm Corporation Ein narkotikum enthaltende aerosolformulierung
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
ATE301991T1 (de) † 1996-12-04 2005-09-15 Link Products Ltd Arzneimittel zusammensetzungen und vorrichtungen zu deren verabreichung
DK1014943T3 (da) † 1997-02-05 2002-10-14 Jago Res Ag Medicinske aerosolformuleringer

Also Published As

Publication number Publication date
PT920302E (pt) 2002-11-29
NO990594L (no) 1999-04-13
GB2326334A (en) 1998-12-23
WO1998056349A1 (en) 1998-12-17
IN189317B (de) 2003-02-08
IL128484A0 (en) 2000-01-31
CZ295521B6 (cs) 2005-08-17
EP0920302B2 (de) 2006-06-21
RS51274B (sr) 2010-12-31
BG63906B1 (bg) 2003-06-30
HUP0001339A3 (en) 2000-10-30
AU8626298A (en) 1998-12-30
SK17699A3 (en) 1999-07-12
ME00333B (me) 2011-02-10
HK1022271A1 (en) 2000-08-04
BR9805993B1 (pt) 2009-05-05
BR9805993A (pt) 1999-08-31
EA199900201A1 (ru) 1999-06-24
HUP0001339A2 (hu) 2000-09-28
ATE222751T1 (de) 2002-09-15
AU729966B2 (en) 2001-02-15
ZA985136B (en) 1999-01-07
DZ2516A1 (fr) 2004-11-08
SI0920302T1 (en) 2002-12-31
CA2263445C (en) 2008-09-09
EE03664B1 (et) 2002-04-15
KR20000068171A (ko) 2000-11-25
ID21491A (id) 1999-06-17
AR012977A1 (es) 2000-11-22
ES2182351T3 (es) 2003-03-01
GB9712434D0 (en) 1997-08-13
MA26507A1 (fr) 2004-12-20
EP0920302A1 (de) 1999-06-09
CO4940408A1 (es) 2000-07-24
DE69807420T2 (de) 2003-05-08
PL193721B1 (pl) 2007-03-30
KR100546239B1 (ko) 2006-01-26
JP2000516965A (ja) 2000-12-19
ITMI971798A1 (it) 1999-01-28
SI0920302T2 (sl) 2006-10-31
PL331531A1 (en) 1999-07-19
CN1138532C (zh) 2004-02-18
BG103221A (en) 1999-09-30
TNSN98087A1 (fr) 2005-03-15
NO327775B1 (no) 2009-09-21
EP0920302B1 (de) 2002-08-28
JP4380802B2 (ja) 2009-12-09
EP1219293A2 (de) 2002-07-03
EE9900055A (et) 1999-08-16
NZ334149A (en) 2000-07-28
MY119074A (en) 2005-03-31
NO990594D0 (no) 1999-02-09
CZ46299A3 (cs) 1999-07-14
EA001259B1 (ru) 2000-12-25
HU228487B1 (en) 2013-03-28
SK284430B6 (sk) 2005-04-01
SA98190821B1 (ar) 2006-11-19
HRP980317A2 (en) 1999-04-30
IT1293803B1 (it) 1999-03-10
IS2435B (is) 2008-10-15
MEP44008A (en) 2011-02-10
IS4974A (is) 1999-02-11
CN1229355A (zh) 1999-09-22
YU6999A (sh) 2000-03-21
ES2182351T5 (es) 2007-03-16
GEP20012462B (en) 2001-06-25
UA70289C2 (uk) 2004-10-15
DK0920302T3 (da) 2002-12-23
TW555570B (en) 2003-10-01
HRP980317B1 (en) 2002-06-30
DK0920302T4 (da) 2006-10-09
IL128484A (en) 2004-09-27
DE69807420T3 (de) 2006-11-16
CA2263445A1 (en) 1998-12-17
EP1219293A3 (de) 2003-05-28
TR199900288T1 (xx) 1999-09-21

Similar Documents

Publication Publication Date Title
ATE222751T1 (de) Pharmazeutische aerosolzusammensetzung
DE69904312D1 (de) Pharmazeutische aerosolformulierung
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
ID24654A (id) Formulasi farmasi omeprazola
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
DE69530325D1 (de) Aerosol-arzneiformulierungen
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
EE9900545A (et) Farmatseutiline kompositsioon
DE69614407T2 (de) Pharmazeutische zusammensetzungen
DE69830154D1 (de) Pharmazeutische zusammensetzungen
DE69708130D1 (de) A-oxo-butansäuren enthaltende pharmazeutische zusammensetzung
ID25857A (id) Komposisi farmasi
ID23531A (id) Komposisi farmasi
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger
BR1100755A (pt) composição farmacêutica
BR1101151A (pt) Compostos e composição farmacêutica
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings